US biopharmaceutical firm Apollomics raises $124m led by Ping An Capital

US biopharmaceutical firm Apollomics raises $124m led by Ping An Capital

Photo: Bloomberg

Apollomics, Inc., an incubator project by US healthcare fund manager OrbiMed Asia, announced on Friday that it has raised $124.2 million in a Series C round of financing led by China’s Ping An Insurance Group’s investment vehicle Ping An Capital and joined by a slew of undivulged new and existing investors.